June 2026
The global knee osteoarthritis injectable treatments market size is estimated to hit around USD 6.78 billion by 2035 from USD 3.70 billion in 2026, with a CAGR of 6.96%.
September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
September 2026
The global aesthetic injectables market size is estimated to hit around USD 43.98 billion by 2035 increasing from USD 15.51 billion in 2026, with a CAGR of 12.28%.
September 2026
The injectable drug delivery market reached USD 829.98 billion in 2026, with prominent companies such as Sandoz, therumo, schott ag, gerresheimer, ypsormed leading the injectable drug delivery market.
September 2026
The global facial injectable market size is expected to increase from USD 16.15 billion in 2026 to hit around USD 44.05 billion by 2035, with a CAGR of 11.82%.
September 2026
The global generic injectable market size is expected to increase from USD 152.01 billion in 2026 and is expected to reach around USD 482.50 billion by 2035 with a CAGR of 13.72%.
September 2026
The global cementless total knee arthroplasty market size is predicted to surpass around USD 28.29 billion by 2035 from USD 5.78 billion in 2026, with a solid CAGR of 19.97%.
September 2026
The global knee replacement market size is expected to increase from USD 11.64 billion in 2026 and is expected to hit around US 18.15 billion by 2035, with a CAGR of 5.08%.
September 2026
The global non-injectable insulin market size is expected to increase from USD 2.13 billion in 2026 and is expected to hit around USD 5.63 billion by 2034 at a CAGR of 12.99%.
September 2026
The generic sterile injectable market size is estimated to hit around USD 124.44 billion by 2035 increasing from USD 56.41 billion in 2026, with a CAGR of 9.29%.
September 2026
The next-gen dermatology treatments market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
September 2026
The global injectable peptides drugs market size was evaluated at USD 53.07 billion in 2026 and is predicted to hit around USD 117.18 billion by 2035, growing at a CAGR of 9.20%.
September 2026
The global injectable cytotoxic drugs market size is estimated to hit around USD 35.71 billion by 2034 increasing from USD 21.99 billion in 2026, with a CAGR of 6.25%.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
July 2026
The next gen cardiovascular treatments market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
July 2026
The global medical aesthetic treatments market growth is fueled by advancements in laser technology, injectables, and rising patient preference for aesthetic care.
June 2026
The global sterile injectables CDMO market size is estimated to hit around USD 11.82 billion by 2035 from USD 5.19 billion in 2026, with a CAGR of 9.59%.
June 2026
The U.S. generic sterile injectable market size was evaluated at USD 17.91 billion in 2025 and is predicted to hit around USD 43.26 billion by 2035, growing at a CAGR of 9.22%.
December 2025
The osteoarthritis therapeutics market size accounted for USD 10.84 billion in 2025 and is expected to hit around USD 26.31 billion by 2035 with a CAGR of 9.27%.
August 2025
The global long-acting injectables (LAIs) market size was evaluated at USD 16.94 billion in 2024 and is predicted to hit around USD 57.26 billion by 2034, growing at a CAGR of 12.95%.
August 2025
The global epidermal growth factors (EGFs) market size is estimated to hit around USD 1.72 billion by 2034 increasing from USD 1.19 billion in 2024, with a CAGR of 3.75%.
July 2025
The global antibody therapy market size reached USD 313.47 billion in 2024 and is predicted to surpass around USD 973.60 billion by 2034, with a solid CAGR of 12%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com